- Home
- ANTX vs FNWD Comparison
ANTX vs FNWD Comparison
Compare ANTX & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | FNWD |
|---|---|---|
| Founded | 2017 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 187.1M |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ANTX | FNWD |
|---|---|---|
| Price | $4.34 | $41.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 287.5K | 7.8K |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.81 |
| Revenue Next Year | N/A | $5.26 |
| P/E Ratio | ★ N/A | $41.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $30.05 |
| 52 Week High | $7.19 | $45.90 |
Technical Indicators
Market Signals| Indicator | ANTX | FNWD |
|---|---|---|
| Relative Strength Index (RSI) | 31.87 | 44.01 |
| Support Level | $3.91 | $41.49 |
| Resistance Level | $5.21 | $44.01 |
| Average True Range (ATR) | 0.39 | 0.63 |
| MACD | -0.08 | -0.08 |
| Stochastic Oscillator | 6.29 | 24.86 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.